| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT02002650 | Post-ERCP Acute Pancreatitis | Drug: Pre-ERCP rectal Indomethacin|Drug: Post-operational Rectal Indomethacin | Fourth Military Medical University | | 2013-12-01 | 2016-05-27 |
| NCT02110810 | Post ERCP Acute Pancreatitis | Drug: Indomethacin|Drug: 2.6-g suppository of glycerin | Instituto Mexicano del Seguro Social | Phase 3 | 2014-01-01 | 2015-03-23 |
| NCT02642601 | Difficult Embryo Transfer | Drug: Indomethacin(KAHIRA PHARMA&CHEM,IND,CO.CAIRO-EGYPT) | Cairo University | Phase 2|Phase 3 | 2014-03-01 | 2015-12-24 |
| NCT02111707 | Acute Pancreatitis | Drug: Rectal indomethacin 100mg one time before or after ERCP | University of Alberta | Phase 4 | 2014-04-01 | 2016-09-14 |
| NCT02633969 | Pain, Postoperative | Drug: Indomethacin Capsules low dose|Drug: Indomethacin Capsules high dose | Iroko Pharmaceuticals, LLC | Phase 2 | 2015-12-01 | 2017-01-27 |
| NCT01869361 | Preterm Labor | Drug: Indomethacin|Drug: Placebo | MetroHealth Medical Center | | 2016-11-01 | 2016-09-13 |
| NCT02692391 | Acute Pancreatitis | Drug: Indomethacin|Drug: Placebo | University of Pittsburgh | Phase 3 | 2014-07-01 | 2017-02-02 |
| NCT02221219 | Intraventricular Hemorrhage|Periventricular Leukomalacia|Brain Injury|Renal Injury | Drug: Indomethacin|Procedure: delay in umbilical cord clamp at birth | John Bauer|University of Kentucky | Phase 1|Phase 2 | 2014-08-01 | 2014-08-19 |
| NCT00750581 | Patent Ductus Arteriosus | Drug: Indomethacin | University of Calgary | Phase 2|Phase 3 | 2008-08-01 | 2016-08-17 |
| NCT01774604 | Post-ERCP Acute Pancreatitis | Drug: Indomethacin|Drug: Placebo | Dartmouth-Hitchcock Medical Center | Phase 3 | 2013-01-01 | 2016-09-28 |
| NCT02935205 | Metastatic Prostate Carcinoma|Recurrent Prostate Carcinoma|Stage IV Prostate Cancer | Drug: Enzalutamide|Drug: Indomethacin | University of California, Davis|National Cancer Institute (NCI) | Phase 1|Phase 2 | 2017-01-01 | 2016-10-13 |
| NCT01073670 | Hemorrhage | Drug: Indomethacin|Drug: Acetaminophen & Indomethacin|Drug: Acetaminophen | Queen's University | Phase 4 | 2000-08-01 | 2010-02-22 |
| NCT01360034 | Obstetric Labor, Premature | Drug: Nifedipine|Drug: Indomethacin | Saint Thomas Hospital, Panama | Phase 3 | 2015-12-01 | 2015-01-01 |
| NCT02711358 | Family Planning | Drug: indomethacin suppositories|Drug: placebo | Assiut University | Phase 4 | 2016-03-01 | 2016-11-28 |
| NCT00728117 | Patent Ductus Arteriosus | Other: feeding|Other: fasting | University of California, San Francisco | | 2008-07-01 | 2012-11-08 |
| NCT01957215 | Ankle Sprain | Drug: Indomethacin|Drug: Placebo | GlaxoSmithKline|Rundo International Pharmaceutical Research & Development Co.,Ltd. | Phase 4 | 2013-10-01 | 2015-05-21 |
| NCT02438371 | Preterm Labor | Drug: Nifedipine|Drug: Indomethacin | The University of Texas Health Science Center, Houston | Phase 4 | 2015-05-01 | 2015-12-03 |
| NCT02476279 | Post-ERCP Pancreatitis | Other: Indomethacin 100 mg rectally immediately after ERCP, NO prophylactic pancreatic stent placement|Other: Indomethacin 100 mg rectally immediately after ERCP AND prophylactic pancreatic stent placement | Medical University of South Carolina|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 | 2015-09-01 | 2016-09-12 |
| NCT00009646 | Infant, Very Low Birth Weight|Infant, Premature|Ductus Arteriosus, Patent | Drug: indomethacin|Drug: Indomethacin|Drug: Placebo | NICHD Neonatal Research Network|Medical Research Council of Canada|National Center for Research Resources (NCRR) | Phase 3 | 1993-11-01 | 2015-06-03 |
| NCT02116309 | Post-ERCP Acute Pancreatitis | Drug: Rectal Indomethacin|Drug: Epinephrine | Johns Hopkins University|American Society for Gastrointestinal Endoscopy|Asian Institute of Gastroenterology, India|Postgraduate Institute of Medical Education and Research|Apollo Gleneagles Hospitals, Kolkata | | 2014-08-01 | 2017-03-01 |
